Skip to main content
SURGICAL INNOVATIONS GROUP PLC logo

SURGICAL INNOVATIONS GROUP PLC — Investor Relations & Filings

Ticker · SUN ISIN · GB0004016704 LEI · 2138004GHGUH3HUZE156 IL Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2022-03-10 Report Publication Anno…
Country GB United Kingdom
Listing IL SUN

About SURGICAL INNOVATIONS GROUP PLC

https://www.surgicalinnovations.com/

Surgical Innovations Group PLC designs, develops, manufactures, and distributes medical devices for minimally invasive surgery (MIS). The company specializes in creating sustainable and innovative solutions that aim to reduce the environmental impact of surgical procedures. A core part of its portfolio is the "Resposable®" technology, which integrates reusable and disposable components to offer clinically effective and environmentally conscious alternatives to single-use instruments. In addition to its branded products, the group provides original equipment manufacturing (OEM) services, engineering, and manufacturing for other medical device companies. The focus is on providing high-quality, accessible products for healthcare professionals performing keyhole surgery.

Recent filings

Filing Released Lang Actions
Notice of Annual Results
Report Publication Announcement Classification · 99% confidence The document is titled "Notice of Annual Results" and explicitly states that the company "will release its audited results for the year ended 31 December 2021 on Wednesday 23 March 2022." It also mentions subsequent analyst and investor briefings related to these final results. This is not the full Annual Report (10-K) or the Interim Report (IR), nor is it the actual results announcement (ER). Instead, it is an announcement about *when* the results will be released, which fits the definition of a Report Publication Announcement (RPA). The presence of the RNS Number and the footer confirming it is provided by RNS further supports this being a regulatory announcement about a future event.
2022-03-10 English
Year-end Trading Update
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and contains a 'Year-end Trading Update' for the period ended 31 December 2021. It provides key financial highlights (revenue expectations, gross margin, adjusted EBITDA, net cash) and outlook commentary, but explicitly states that formal earnings guidance is being withheld until final results in March. This structure—a brief update on trading performance before the full annual report—is characteristic of an Earnings Release (ER). Although it is distributed via RNS, the content is specifically an earnings update, making ER the most precise classification over the general RNS fallback. The length (8135 chars) is substantial enough to be the release itself, not just a notification of a release. FY 2021
2022-01-17 English
Changes to Board Structure & CFO Appointment
Board/Management Information Classification · 99% confidence The document is an official announcement released via RNS (Regulatory News Service) on November 15, 2021. The content explicitly details 'Planned changes to board structure and composition and appointment of Charmaine Day FCCA as Chief Financial Officer' and the stepping down of two other directors. This directly relates to changes in senior management and the board of directors. Therefore, the most appropriate classification is Board/Management Information (MANG). Although it is distributed via RNS, the specific content is not general regulatory news but a specific management announcement.
2021-11-15 English
Grant of Options
Remuneration Information Classification · 99% confidence The document is a formal announcement released via RNS (Regulatory News Service) of the London Stock Exchange, indicated by the RNS Number and the concluding boilerplate text. The content details the 'Grant of Options' under an Enterprise Management Incentive scheme to key personnel, including the Company Secretary. This type of announcement, which involves the issuance of securities (options) and subsequent disclosure of insider dealings (PDMR dealing notification for Charmaine Day), falls under corporate actions related to capital or insider transactions. Since the core event is the grant of options and the disclosure of resulting insider holdings, it relates closely to share capital changes or insider trading reports. However, the structure strongly resembles a standard regulatory disclosure made through RNS. The specific content—granting options and detailing PDMR transactions—is often captured under general regulatory filings or specific transaction types. Given the options grant and the subsequent PDMR disclosure, it is a regulatory announcement. It is not a Director's Dealing (DIRS) as it's an option grant, not a simple trade, nor is it a Share Issue (SHA) as it's an option grant, not a general share issue. It is a mandatory regulatory disclosure made via RNS. Since the document is a full announcement detailing a specific corporate action (grant of options) and includes mandatory regulatory tables (PDMR dealing), it fits best under the general 'Regulatory Filings' (RNS) category, as it is a primary, non-financial report regulatory release.
2021-11-10 English
Half-year Report
Interim / Quarterly Report Classification · 100% confidence The document is a 'Half-year Report' for Surgical Innovations Group plc for the six-month period ended 30 June 2021. It contains detailed financial highlights, operational updates, a Chairman's statement, and financial performance analysis. Since it provides comprehensive financial results for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report. H1 2021
2021-09-15 English
Notice of Interim Results
Investor Presentation Classification · 99% confidence The document is a formal announcement disseminated via RNS (RNS Number : 9299J) by Surgical Innovations Group plc. The core content announces the upcoming release of 'interim results for the six months ended 30 June 2021' and details the schedule for an 'Analyst Briefing' and an 'Investor Presentation' related to these results. Since the document is an announcement about the forthcoming release of interim financial results and associated investor events, rather than the full interim report itself, it fits the definition of a Report Publication Announcement (RPA). It explicitly states when the results will be released (September 15, 2021) and schedules follow-up events, aligning perfectly with the RPA definition: 'Announcement regarding the timing, release, or publication of company reports (often stating the report is attached or available on the website)'. The document length (5819 chars) is moderate, but the content is purely an announcement of future events/reports.
2021-08-27 English

Browse filings by year

36 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.